BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/26/2024 7:56:29 AM | Browse: 94 | Download: 157
 |
Received |
|
2023-10-17 03:42 |
|
Peer-Review Started |
|
2023-10-17 03:44 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-12-06 04:59 |
|
Revised |
|
2023-12-15 16:40 |
|
Second Decision |
|
2024-01-10 02:42 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2024-01-10 05:05 |
|
Articles in Press |
|
2024-01-10 05:05 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-01-20 15:23 |
|
Publish the Manuscript Online |
|
2024-01-26 07:56 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Leukocyte immunoglobulin-like receptor B2: A promising biomarker for colorectal cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Wen-Zhuo Zhao, Hong-Gang Wang and Xiao-Zhong Yang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Xiao-Zhong Yang, MD, PhD, Chief Doctor, Doctor, Professor, Department of Gastroenterology, The Affiliated Huai'an No. 1 People's Hospital of Nanjing Medical University, No. 1 Huanghe Road, Huai'an 223300, Jiangsu Province, China. hayyyxzh@njmu.edu.cn |
| Key Words |
Colorectal cancer; Leukocyte immunoglobulin-like receptor B2; Angiopoietin-like protein 2; Therapeutic target; Noninvasive screening biomarker |
| Core Tip |
In this study, it has been extensively demonstrated that there is an overexpression of leukocyte immunoglobulin-like receptor B2 (LILRB2) and its ligand angiopoietin-like protein 2 in colorectal cancer tissues. Furthermore, these proteins have been found to be closely associated with tumor progression and poor prognosis. The author conducted an analysis of LILRB2 serum concentration using 313 serum samples and compared its advantages and disadvantages with traditional tumor markers such as carcinoembryonic antigen and carbohydrate antigen 199. However, we believe that certain aspects of data collection and analysis in the article warrant further consideration. Therefore, we would like to discuss our perspective on this intriguing research. |
| Publish Date |
2024-01-26 07:56 |
| Citation |
Zhao WZ, Wang HG, Yang XZ. Leukocyte immunoglobulin-like receptor B2: A promising biomarker for colorectal cancer. World J Gastroenterol 2024; 30(4): 421-423 |
| URL |
https://www.wjgnet.com/1007-9327/full/v30/i4/421.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v30.i4.421 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
